USANA Health Sciences Revenue 2006-2019 | USNA

USANA Health Sciences revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
USANA Health Sciences Annual Revenue
(Millions of US $)
2018 $1,189
2017 $1,047
2016 $1,006
2015 $918
2014 $790
2013 $718
2012 $649
2011 $582
2010 $518
2009 $437
2008 $429
2007 $423
2006 $365
2005 $315
USANA Health Sciences Quarterly Revenue
(Millions of US $)
Q2 2019 $256
Q1 2019 $273
Q4 2018 $299
Q3 2018 $297
Q2 2018 $301
Q1 2018 $292
Q4 2017 $273
Q3 2017 $262
Q2 2017 $257
Q1 2017 $255
Q4 2016 $253
Q3 2016 $254
Q2 2016 $259
Q1 2016 $240
Q4 2015 $233
Q3 2015 $233
Q2 2015 $233
Q1 2015 $219
Q4 2014 $228
Q3 2014 $192
Q2 2014 $188
Q1 2014 $182
Q4 2013 $186
Q3 2013 $174
Q2 2013 $189
Q1 2013 $169
Q4 2012 $169
Q3 2012 $165
Q2 2012 $161
Q1 2012 $154
Q4 2011 $146
Q3 2011 $144
Q2 2011 $149
Q1 2011 $144
Q4 2010 $138
Q3 2010 $135
Q2 2010 $126
Q1 2010 $119
Q4 2009 $117
Q3 2009 $111
Q2 2009 $112
Q1 2009 $97
Q4 2008 $111
Q3 2008 $107
Q2 2008 $109
Q1 2008 $102
Q4 2007 $109
Q3 2007 $106
Q2 2007 $108
Q1 2007 $101
Q4 2006 $95
Q3 2006 $92
Q2 2006 $90
Q1 2006 $88
Q4 2005 $74
Q3 2005 $82
Q2 2005 $82
Q1 2005 $77
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.535B $1.189B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.466B 37.86
Takeda Pharmaceutical (TAK) Japan $54.955B 8.60
Astellas Pharma (ALPMY) Japan $30.027B 14.31
Merck (MKGAF) Germany $14.908B 20.34
Eisai (ESALY) Japan $14.633B 22.40
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.157B 18.06
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.635B 18.62
Neurocrine Biosciences (NBIX) United States $8.562B 0.00
IPSEN SA ADR (IPSEY) France $8.332B 0.00
Sage Therapeutics (SAGE) United States $7.452B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Catalent (CTLT) United States $7.196B 28.44
Jazz Pharmaceuticals (JAZZ) Ireland $6.684B 8.80
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.194B 18.67
United Therapeutics (UTHR) United States $3.594B 0.00
FibroGen (FGEN) United States $3.378B 84.48
Evotec AG (EVTCY) Germany $3.277B 44.87
Arrowhead Pharmaceuticals (ARWR) United States $3.256B 74.66
Nektar Therapeutics (NKTR) United States $3.031B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.912B 10.44
PTC Therapeutics (PTCT) United States $2.228B 0.00
Tilray (TLRY) Canada $2.160B 0.00
Xencor (XNCR) United States $1.988B 43.35
Zogenix (ZGNX) United States $1.879B 0.00
Portola Pharmaceuticals (PTLA) United States $1.874B 0.00
Corcept Therapeutics (CORT) United States $1.633B 22.44
Pacira Pharmaceuticals (PCRX) United States $1.586B 57.73
Heron Therapeutics (HRTX) United States $1.424B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.413B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.203B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.171B 19.31
ArQule (ARQL) United States $1.038B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.956B 0.00
TherapeuticsMD (TXMD) United States $0.944B 0.00
Aerie Pharmaceuticals (AERI) United States $0.932B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.873B 3.89
Spectrum Pharmaceuticals (SPPI) United States $0.870B 0.00
Dova Pharmaceuticals (DOVA) United States $0.809B 0.00
Endo (ENDP) Ireland $0.790B 1.39
Organogenesis Holdings (ORGO) United States $0.719B 0.00
Karyopharm Therapeutics (KPTI) United States $0.647B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.542B 0.00
Flexion Therapeutics (FLXN) United States $0.539B 0.00
Akebia Therapeutics (AKBA) United States $0.513B 0.00
Indivior (INVVY) United States $0.473B 1.71
Aptorum Group (APM) Hong Kong, SAR China $0.466B 0.00
Lannett Co Inc (LCI) United States $0.453B 4.77
ChemoCentryx (CCXI) United States $0.450B 0.00
Siga Technologies (SIGA) United States $0.446B 1.04
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.440B 0.00
Translate Bio (TBIO) United States $0.426B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.406B 0.00
Collegium Pharmaceutical (COLL) United States $0.403B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.366B 16.64
ImmunoGen (IMGN) United States $0.366B 0.00
Innate Pharma SA (IPHYF) France $0.363B 0.00
DURECT (DRRX) United States $0.355B 0.00
Rafael Holdings (RFL) United States $0.334B 0.00
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.313B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Dermira (DERM) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.283B 0.00
Ardelyx (ARDX) United States $0.277B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.276B 0.00
Molecular Templates (MTEM) United States $0.260B 0.00
Recro Pharma (REPH) United States $0.258B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.217B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.206B 0.00
GlycoMimetics (GLYC) United States $0.199B 0.00
CannTrust Holdings (CTST) Canada $0.195B 0.00
CV Sciences (CVSI) United States $0.193B 0.00
KalVista Pharmaceuticals (KALV) United States $0.191B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 30.45
AcelRx Pharmaceuticals (ACRX) United States $0.175B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Concert Pharmaceuticals (CNCE) United States $0.148B 0.00
Calithera Biosciences (CALA) United States $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
IMV INC (IMV) Canada $0.129B 0.00
Generex Biotechnology (GNBT) United States $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.128B 0.00
MEI Pharma (MEIP) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.110B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.53
Aquestive Therapeutics (AQST) United States $0.084B 0.00
Majesco Entertainment (PTE) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Lipocine (LPCN) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
Genocea Biosciences (GNCA) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.065B 9.73
Novan (NOVN) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Capnia (SLNO) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.031B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Opexa Therapeutics (ACER) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00